Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyAndrea Chiricozzi, Niccolò Gori, Anna Balato et al.|Expert Opinion on Biological Therapy|2023Cited by 10
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyAndrea Chiricozzi, Ketty Peris, Silvia Mariel Ferrucci et al.|Figshare|2023Cited by 0